32 related articles for article (PubMed ID: 18480991)
1. CTPC, a combined transcriptome data set of human prostate cancer cell lines.
Cheng S; Yu X
Prostate; 2023 Feb; 83(2):158-161. PubMed ID: 36207780
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic Characterization of 2D and 3D Prostate Cancer Cell Systems Using Electrical Impedance Spectroscopy.
Crowell LL; Yakisich JS; Aufderheide B; Adams TNG
Biosensors (Basel); 2023 Dec; 13(12):. PubMed ID: 38131796
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of SELDI Spectra Across Time and Laboratories.
Diao L; Clarke CH; Coombes KR; Hamilton SR; Roth J; Mao L; Czerniak B; Baggerly KA; Morris JS; Fung ET; Bast RC
Cancer Inform; 2011 Mar; 10():45-64. PubMed ID: 21552492
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis.
Sun W; Ye Z; Mi Z; Shi T; Han C; Guo S
J Huazhong Univ Sci Technolog Med Sci; 2008 Apr; 28(2):174-8. PubMed ID: 18480991
[TBL] [Abstract][Full Text] [Related]
5. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2009 Dec; 22(6):1451-8. PubMed ID: 19885599
[TBL] [Abstract][Full Text] [Related]
6. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
[TBL] [Abstract][Full Text] [Related]
7. Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines.
Gao H; Song Q; Yang J; Yu S; Zhao J; Yu G
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):104-108. PubMed ID: 28886322
[TBL] [Abstract][Full Text] [Related]
8. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
[TBL] [Abstract][Full Text] [Related]
9. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy.
Johansson B; Pourian MR; Chuan YC; Byman I; Bergh A; Pang ST; Norstedt G; Bergman T; Pousette A
Prostate; 2006 Sep; 66(12):1235-44. PubMed ID: 16705742
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
Ghosh R; Garcia GE; Crosby K; Inoue H; Thompson IM; Troyer DA; Kumar AP
Neoplasia; 2007 Nov; 9(11):893-9. PubMed ID: 18030357
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
